Lumos Diagnostics HoldingsASX:LDX 31 Days Inventory is 73.99 as of Dec. 2025, which is 30% below its 10-year median of 105.80. GuruFocus rates ASX:LDX with a GF Score™ of 31/100 and a GF Value™ of A$0.02 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Lumos Diagnostics Holdings ranks better than 86.64% on this metric.
The historical rank and industry rank for Lumos Diagnostics Holdings's Days Inventory or its related term are showing as below:
ASX:LDX'
s Days Inventory Range Over the Past 10 Years
Min: 51.24 Med: 105.8 Max: 138.99
Current: 80.48
During the past 4 years, Lumos Diagnostics Holdings's highest Days Inventory was 138.99. The lowest was 51.24. And the median was 105.80.
ASX:LDX's Days Inventory is ranked better than 86.64% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs ASX:LDX: 80.48
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lumos Diagnostics Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lumos Diagnostics Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.13.
Lumos Diagnostics Holdings (ASX:LDX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lumos Diagnostics Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lumos Diagnostics Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lumos Diagnostics Holdings Days Inventory Related Terms
Lumos Diagnostics Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:LDX vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Lumos Diagnostics Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumos Diagnostics Holdings Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumos Diagnostics Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Lumos Diagnostics Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumos Diagnostics Holdings (ASX:LDX) has a Days Inventory of 73.99 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lumos Diagnostics Holdings and its competitors. This is 30% below median its historical median of 105.80. Over the past decade, Lumos Diagnostics Holdings' Days Inventory has ranged from 51.24 to 138.99. According to the industry distribution chart, Lumos Diagnostics Holdings ranks #105 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 13.4%.
Is Lumos Diagnostics Holdings' Days Inventory too high?
Lumos Diagnostics Holdings' current Days Inventory of 73.99 is 30% below median its 10-year median of 105.80. Over the past 10 years, this metric has ranged from a low of 51.24 to a high of 138.99. The Medical Devices & Instruments industry median Days Inventory is 179.60. Lumos Diagnostics Holdings' value of 73.99 is 58.8% below this industry median. Based on the distribution chart, Lumos Diagnostics Holdings ranks #105 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lumos Diagnostics Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lumos Diagnostics Holdings' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lumos Diagnostics Holdings ranks #105 out of 786 companies for Days Inventory. This places Lumos Diagnostics Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Lumos Diagnostics Holdings' value of 73.99 is 58.8% below this benchmark. Historically, Lumos Diagnostics Holdings' own Days Inventory has ranged from 51.24 to 138.99 over the past decade. While the company's 10-year median is 105.80 vs. the industry median of 179.60, Lumos Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumos Diagnostics Holdings's current Days Inventory of 73.99 is 58.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lumos Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumos Diagnostics Holdings's current Days Inventory is 73.99, which is 30% below median its own 10-year median of 105.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumos Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lumos Diagnostics Holdings (ASX:LDX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.11 — trading 425% above its estimated fair value. The current Days Inventory is 73.99, which is 30% below median its 10-year median of 105.80 and 58.8% below the Medical Devices & Instruments industry median of 179.60. Lumos Diagnostics Holdings' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lumos Diagnostics Holdings (ASX:LDX), the current Days Inventory is 73.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lumos Diagnostics Holdings (ASX:LDX) Overvalued in 2026?
Based on GuruFocus' analysis, Lumos Diagnostics Holdings stock appears to be overvalued.
The current stock price of A$0.11 is trading 425% above its estimated GF Value™ of A$0.02.
GuruFocus considers Lumos Diagnostics Holdings to be Significantly Overvalued.
Key valuation signals for ASX:LDX:
Days Inventory: 73.99 (30% below median its 10-year median of 105.80)
GF Value™: A$0.02 vs. price of A$0.11 (425% above fair value)
Industry Position: 58.8% below the Medical Devices & Instruments median (#105 of 786)
No single metric tells the full story. See the ASX:LDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services. The Company operates in two geographical regions, the United States and Australia and the majority of revenue is generated from the United States.
31GF Score
Get the complete analysis for ASX:LDX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LDX has been successfully added to your 
